77 reports of this reaction
3.6% of all OMEPRAZOLE, SODIUM BICARBONATE reports
#5 most reported adverse reaction
END STAGE RENAL DISEASE is the #5 most commonly reported adverse reaction for OMEPRAZOLE, SODIUM BICARBONATE, manufactured by CVS Pharmacy. There are 77 FDA adverse event reports linking OMEPRAZOLE, SODIUM BICARBONATE to END STAGE RENAL DISEASE. This represents approximately 3.6% of all 2,134 adverse event reports for this drug.
Patients taking OMEPRAZOLE, SODIUM BICARBONATE who experience end stage renal disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
END STAGE RENAL DISEASE is moderately reported among OMEPRAZOLE, SODIUM BICARBONATE users, representing a notable but not dominant share of adverse events.
In addition to end stage renal disease, the following adverse reactions have been reported for OMEPRAZOLE, SODIUM BICARBONATE:
The following drugs have also been linked to end stage renal disease in FDA adverse event reports:
END STAGE RENAL DISEASE has been reported as an adverse event in 77 FDA reports for OMEPRAZOLE, SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
END STAGE RENAL DISEASE accounts for approximately 3.6% of all adverse event reports for OMEPRAZOLE, SODIUM BICARBONATE, making it a notable side effect.
If you experience end stage renal disease while taking OMEPRAZOLE, SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.